Translational scientist Robert Wechsler-Reya, PhD, an expert in pediatric brain cancer, has joined the Herbert Irving Comprehensive Cancer Center as scientific director of Brain Tumor Research.
Dr. Ghosh has been elected to the National Academy of Medicine for pioneering studies of NF-kB and establishing strategies to target NF-kB in the treating inflammatory diseases and cancer.
Congratulations to Lauren Houghton, Chin Hur, Markus D. Siegelin, and Neil Vasan, the new Class of Velocity Fellows, for their innovative, life-changing cancer research.
Annual Precision Medicine Pilot Grants are awarded to five Columbia research teams, including research led by members Drs. Brent Stockwell and Kelley Yan.
A multi-institution team of lung cancer experts have received a new SU2C grant to bring technology-enabled immunotherapy monitoring to under-represented patients.
The American Society of Clinical Oncology (ASCO) and Conquer Cancer Foundation have recognized seven leading oncology trainees from Columbia Cancer with Young Investigator Awards and Merit Awards.
Michael Shen, PhD, the Arthur J. Antenucci Professor of Medical Sciences, has been elected to the 2021 class of new fellows of the American Association for the Advancement of Science (AAAS).
Dr. Barbara Pro, a leader in lymphoma research and care, has been named clinical director of the lymphoma program at the Herbert Irving Comprehensive Cancer Center (HICCC).
The new Center will build upon the dedicated MDS program at Columbia University, a longstanding program of excellence that has served as a national leader in MDS research.